Soroush T. Bazargani

Soroush T. Bazargani

Auto-generated profile, based on publicly available information

Soroush T. Bazargani

Los Angeles, CA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
JFJane Figueiredo
Jane Figueiredo
TCThomas G. Clifford
Thomas G. Clifford
SBSoroush T. Bazargani
Soroush T. Bazargani
MLMichael Lin-Brande
Michael Lin-Brande
GMGus Miranda
Gus Miranda
SDSiamak Daneshmand
Siamak Daneshmand

1 January 2019 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
SBSoroush T. Bazargani
Soroush T. Bazargani
TCThomas G. Clifford
Thomas G. Clifford
HDHooman Djaladat
Hooman Djaladat
ASAnne K. Schuckman
Anne K. Schuckman
KWKevin Wayne
Kevin Wayne
SDSiamak Daneshmand
Siamak Daneshmand

4 June 2021 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
Alireza GhoreifiAlireza Ghoreifi
Alireza Ghoreifi
MBMichael F. Basin
Michael F. Basin
SGSaum Ghodoussipour
Saum Ghodoussipour
SBSoroush T. Bazargani
Soroush T. Bazargani
EAErfan Amini
Erfan Amini
Hooman DjaladatHooman Djaladat
Hooman Djaladat

1 September 2019 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
KCKai W. Cheng
Kai W. Cheng
ASAnkeet Shah
Ankeet Shah
SBSoroush Bazargani
Soroush Bazargani
GMGus Miranda
Gus Miranda
JCJie Cai
Jie Cai
Hooman DjaladatHooman Djaladat
Hooman Djaladat

1 January 2021 in Radiology
Verified
Journal Article
Closed access
SBSoroush Bazargani
Soroush Bazargani
MBMark Bandyk
Mark Bandyk
KBKethandapatti C. Balaji
Kethandapatti C. Balaji

1 April 2016 in Journal of Urology
Verified
Journal Article
Closed access
PDF file
SBSoroush T Bazargani
Soroush T Bazargani
TCThomas G. Clifford
Thomas G. Clifford
HDHooman Djaladat
Hooman Djaladat
ASAnne Schuckman
Anne Schuckman
BWBrian Willard
Brian Willard
SDSiamak Daneshmand
Siamak Daneshmand
Blue Light Cystoscopy (BLC) using hexaminolevulinate (Cysview) improves the detection of non-muscle invasive bladder cancer (NMIBC) compared to white light cystoscopy (WLC) alone. However, it is not approved for immediate post-BCG therapy or for repeat use. We report on our experience from the prospective Blue Light Cystoscopy with Cysview Registry and its utility in these scenarios.